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Abstract 
In this Master’s project, I have studied a mammalian serine-threonine kinase NUAK2 implicated in 
human disease but whose molecular functions and interacting proteins are as of yet poorly characterized. 
The goal was to identify new interacting proteins to increase understanding of the molecular functions 
and potentially link to human physiology and disease. Recent work from the host lab shows NUAK2 
loss in cultured primary cells mimics loss of the tumor suppressor LKB1 which also acts upstream of 
NUAK2, together suggesting NUAK2 could be involved in tumor suppression.  
Currently, only two protein-protein interacting proteins with NUAK2 have been identified:  
NUAK2 is targeted to actin stress fibers by the myosin phosphatase Rho-interacting protein (MRIP), and 
it is involved in regulating cell contractility by affecting indirectly the phosphorylation cycle of the myosin 
light chain through inactivation of the myosin phosphatase target subunit 1 (MYPT1).  
In this project, I utilized a novel protein-protein interaction screening method that utilizes proximity-
dependent biotin labeling to identify new interacting proteins with NUAK2 in human embryonic kidney 
cells (HEK 293). This method is based on fusing an E.Coli promiscuous biotin ligase, BirA*(R118G), to the 
investigated protein. The BirA*(R118G) ligase biotinylates all the proteins in close proximity of the fusion 
protein creating a history of protein-protein associations over time. Afterwards, the biotinylated proteins 
can be isolated by affinity purification methods and identified by mass-spectrometry. 
The screening identified the previously known interaction partners of NUAK2 indicating it was 
technically successful. In addition, I also identified in total 108 novel potential protein interaction partners 
for NUAK2. One of the top hits was Cytospin-A, a cross-linking protein between microtubules and actin 
cytoskeleton, supporting a role of NUAK2 as regulator of cytoskeleton. Supporting the validity of our 
finding, Cytospin-A depletion in mammalian cells causes defective actin-cytoskeleton reorganization, a 
very similar phenotype seen with NUAK2 depletion. 
In future studies, I will continue to investigate the specific role of NUAK2 and Cytospin-A aiming 
for detailed information on the function of NUAK2 in regulation of microtubules and actin cytoskeleton. 
Validation of some of the other identified interactions is expected to provide novel insights to the biology 
and role of NUAK2 in LKB1 tumor suppressor functions.  
Key words: NUAK2, LKB1, protein-protein interactions, proximity-dependent biotin labeling, BioID, 
tumorigenesis.  
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1   Background 
1.1   Kinases are key players in cell signaling in human physiology and cancer cells  
All essential cellular processes like cell growth, proliferation, or differentiation are determined by dynamic 
integration and response to extracellular and intracellular signals. Cells are constrained to their 
environment and their behavior is tightly influenced by it. Phosphorylation is one of the fundamental 
signaling transduction mechanisms cells use to integrate and propagate information. Addition of 
phosphate groups to molecules is a post-translational modification and it usually modifies the 
conformational structure of the target molecule and therefore it alters its function e.g. by changing affinity 
or reactivity to other molecules. Phosphorylation is controlled by transient interactions between protein 
kinases and their substrates. Protein kinases comprise a big family of signaling proteins and they are 
found in all living organisms (Grangeasse et al., 2012; Wang et al., 2010). The human genome contains 
500 genes that encode tyrosine or serine-threonine protein kinases, comprising up to 2% of all genes 
(Manning et al. 2002). The phosphorylation signals are often propagated and amplified through cascades 
of several kinases that are phosphorylated sequentially. Detection and identification of all these transient 
interactions is challenging as they are highly dynamic and fast.  
Since phosphorylation events are involved in all essential cellular processes it is not surprising that 
tumor cells often have many of the protein kinases or their counterparts, protein phosphatases, mutated. 
Tumor cells need to hijack their signaling network to constitutively activate growth and proliferation 
programs as well as to inactivate suicidal behavior, apoptotic programs that otherwise are triggered when 
the cell detects that its signaling has been compromised (Fleuren et al., 2016).  
NUAK2 is a substrate of the tumor suppressor kinase LKB1. The molecular mechanisms by which 
LKB1 functions as a tumor suppressor remain unknown, in part due to limited knowledge of the protein-
protein interactions of its substrates. Loss of NUAK2 in cultured primary cells resembles loss of LKB1 
suggesting NUAK2 could be involved in tumor suppression. Therefore, identifying new partners for 
NUAK2 can bring light to understand its biological functions and its involvement in tumorigenesis.    
1.2   Regulation of NUAK2 
1.2.1   NUAK2 is a substrate of the tumor suppressor kinase LKB1  
NUAK2, also known as sucrose-non-fermenting AMPK-related kinase (SNARK), is a serine-threonine 
kinase of 76 kDa. It was first identified as an ultraviolet induced gene in rat keratinocytes in 2001 
(Lefebvre et al., 2001). NUAK2 belongs to a group of 12 other kinases closely related to the energy 
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sensor AMP-activated kinases (AMPK) subunits α1 and α2. These kinases have been commonly grouped 
as AMPK subfamily or AMPK-related kinases. Their main feature is a conserved kinase catalytic domain 
(Figure 1) (Lizcano et al., 2004). Within the AMPK subfamily, NUAK2 is more closely related to the 
kinase NUAK1. These two kinases differ from the rest of the AMPK subfamily in that they lack an 
ubiquitin associated domain after the C-terminus of the kinase domain (Katajisto et al., 2007). Even 
though mammals have two different genes, C.Elegans has a unique orthologue, UNC-82 (Hoppe et al., 
2010), suggesting NUAK1 and NUAK2 likely derived from a common ancestor gene and therefore they 
could still share cellular functions and interaction partners.   
The AMPK-related kinases, with the exception of MELK, are strongly activated in vitro by 
phosphorylation of a conserved T-loop threonine residue by an upstream serine-threonine kinase, LKB1 
(Figure 1). Full activation of LKB1 kinase activity and subsequent substrate activation requires the 
formation of a complex with the scaffold MO25 protein and the pseudokinase STRAD as this complex 
stabilizes and localizes LKB1 in the cytoplasm (Lizcano et al., 2004). Endogenous activity of the AMPK-
related kinases was dramatically decreased in cells that did not express LKB1 or where LKB1 was 
previously depleted, suggesting LKB1 is a limiting factor in AMPK-related kinases activation, at least in 
vitro (Lizcano et al., 2004).  
 
Figure 1: Dendogram and alignment of the T-loop sequences of the AMPK-related kinases.  
Identical residues are marked in red and conserved residues are marked in yellow. Asterisk indicates the Thr and Ser 
phosphorylation sites of LKB1. The consensus sequence is the optimal sequence for LKB1 phosphorylation suggested by 
Lizcano et al., 2004. X stands for any aminoacid; ∅  represents a large hydrophobic residue; a, g, n, and s indicate 
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preference for Ala, Gly, Asn and Ser, respectively. (Dendogram modified from Cell Signaling Technologies 
(www.cellsignal.com) and T-loop sequences adapted from Lizcano et al., 2004) 
1.2.2   NUAK2 expression is induced by several cell stresses  
AMPK is part of the stress response system of the cells. As its homolog in yeast SNF1, AMPK expression 
is induced by different cell stresses like hypoxia, glucose deprivation or increased intracellular AMP:ATP 
ratio (Hardie, 2007). Induction of AMPK by cellular stresses and further activation by LKB1 
phosphorylation triggers a signaling cascade that through inactivation of the mammalian target of 
rapamycin (mTOR) switches off cellular anabolic pathways and prepares the cell to restore energy storage 
through catabolic metabolism (Xu et al., 2012). Of other kinases of the AMPK subfamily, only NUAK2 
has been found to respond to several cellular stresses. NUAK2 expression in several cell lines is induced 
by nutrient deprivation, like glucose or glutamine deficiency, hypoxia conditions or increased reactive 
oxygen molecules (Lefebvre and Rosen, 2005). However, unlike AMPK, this response to cellular stress 
seems to be highly cell context and cell type dependent as several studies have highlighted (Lefebvre et 
al. 2001; Lizcano et al. 2004; Lefebvre and Rosen 2005). In human myocyte cultures, NUAK2 expression 
is induced by TNFα and palmitate, two stress molecules involved in the acquirement of insulin-resistance 
by skeletal muscle cells (Rune et al., 2009). Even though this insulin-resistance was found to be 
independent of NUAK2 status, as discussed in next section, there is more evidence to suggest NUAK2 
has a role in skeletal muscle metabolism homeostasis, and that it mediates part of the exercise-stimulated 
glucose transport (Koh et al., 2010).  
1.3   Functions of NUAK2 
1.3.1   Role of NUAK2 in skeletal muscle cell metabolism  
Skeletal muscle cells are key players in glucose homeostasis as they are major consumers and storage of 
glucose in adults. Insulin and exercise are the two main stimulators of glucose transport in muscle cells. 
It is well known that in situations of insulin-resistance like diabetes type 2, where insulin-stimulated 
glucose transport is impaired, exercise is highly beneficial as it increases glucose uptake and transport in 
skeletal muscle cells, as well as insulin sensitivity and fatty acid (FA) oxidation (Stanford and Goodyear, 
2014). Insulin and exercise stimulation of glucose transport act through different signaling pathways but 
their signaling converge at the protein kinase B (PKB) substrates paralogs, AS160 (also known as 
TBC1D4) and TBC1D1 increasing their phosphorylation and promoting an increase of the glucose 
transporter (GLUT4) translocation from vesicles to the plasma membrane (Goodyear and Kahn, 1998).  
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Studies using LKB1 muscle-specific knockout mice have identified LKB1 as an important 
molecular regulator of contraction-stimulated glucose transport. Depletion of LKB1 in skeletal muscle 
in mice decreased FA oxidation during treadmill exercise and decreased contraction-stimulated glucose 
transport (Koh et al., 2006). These mice also had reduced AMPKα2 (the predominant AMPK subunit 
in muscle) and lower phosphorylation of AS160 and TBC1D1 (Jeppesen et al., 2013). Even though 
AMPKα2 was dramatically reduced, and was thought to be the sole substrate of LKB1 involved in 
glucose metabolism, further studies using mice lacking AMPKα2 have revealed that AMPK cannot be 
the only LKB1 substrate involved in contraction-stimulated glucose transport. Mice lacking AMPKα2 
only had partially decreased FA oxidation and a slight, or no change at all, in exercise-dependent glucose 
uptake and transport stimulation (Fujii et al., 2005; Jørgensen et al., 2004; Mu et al., 2001). These results 
suggested that LKB1 regulation of glucose homeostasis in muscle cells likely involved more than one 
member of the AMPK subfamily besides AMPKα2.  
Interestingly, NUAK2 heterozygous knockout mice showed premature onset of obesity along 
with increased fat mass, hyperglycemia and hyperinsulinemia (Koh et al., 2010; Tsuchihara et al., 2008), 
all classic features of glucose intolerance and diabetes type 2. Moreover, these mice showed reduced 
contraction-stimulated glucose transport when tested for treadmill exercise, and myocytes derived from 
these mice had also lower phosphorylation of TBC1D1 (Koh et al., 2010). In the same line, mice 
expressing a dominant negative mutant NUAK2 also had impaired contraction-stimulated glucose 
transport suggesting NUAK2 is a specific LKB1 substrate regulating contraction-stimulated glucose 
transport in skeletal muscle cells (Koh et al., 2010). In addition to these studies, obese people have also 
increased levels of NUAK2 in muscle cells and as mentioned before, NUAK2 was severely increased 
when human myocyte cell cultures were exposed to TNFα and palmitate, agents that induce insulin 
resistance (Rune et al., 2009). Acquirement of insulin resistance was independent of NUAK2 levels, as 
depletion of NUAK2 did not revert insulin resistance suggesting induction of NUAK2 in human obesity 
is more likely to be a response to counterbalance insulin resistance effects by increasing exercise-
dependent glucose uptake and transport (Rune et al., 2009).  
1.3.2   NUAK2 promotes actin stress fibers remodeling 
Currently, there are only two known proteins that physically interact with NUAK2. Both of these proteins 
belong to the regulation of the phosphorylation cycle of the myosin light chain (MLC) at the actin stress 
fibers of smooth muscle cells. Changes in ATPase activity of MLC remodels the actin stress fibers 
changing contractility and motility of cells (Kreisberg et al., 1997). Increased phosphorylation of MLC 
causes higher contraction of the actin bundles and subsequent cell detachment and increased cell motility. 
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This phosphorylation is classically regulated by Rho kinase proteins (ROCK), serine/threonine kinases 
that are activated by an upstream small GTPase,  RhoA (Kreisberg et al., 1997). Desphosphorylation of 
MLC is carried out by MLC phosphatase. This protein complex is comprised of a phosphatase regulatory 
subunit (MYPT1) and a phosphatase catalytic subunit (PP1). The MLC phosphatase as well as RhoA are 
recruited to actin stress fibers by the myosin Rho interacting protein (MRIP) (Surks et al., 2005).  
MRIP also recruits NUAK2 to the same location (Vallenius et al., 2011). This interaction is 
needed for NUAK2 inhibition of the phosphatase regulatory subunit (MYPT1) function. The fact that 
presence of NUAK2 at the actin stress fibers prevents dephosphorylation of MLC is thought to be 
partially kinase-independent, as an inactive kinase mutant NUAK2 succeeded to inhibit the phosphatase 
action (Vallenius et al., 2011). However, an independent study has also showed that NUAK2 can directly 
bind and phosphorylate MYPT1 (Yamamoto et al., 2008), indicating that NUAK2 might inhibit the 
phosphatase also in a kinase-dependent manner. In a similar model, the related kinase, NUAK1, has also 
been reported to physically interact with the MLC phosphatase complex, in this case with the catalytic 
subunit PP1, and inactivate the phosphatase by direct phosphorylation of the Ser445, Ser472 and Ser910 
residues of MYPT1, all different sites than the usually phosphorylated by ROCK (Thr696, Thr853) 
(Zagórska et al., 2010). Phosphorylation of MYPT1 recruits the phosphatase to scaffold 14-3-3 proteins 
that trap and keep the phosphatase away from the actin stress fibers and therefore prevents 
dephosphorylation of MLC (Koga and Ikebe, 2008; Zagórska et al., 2010). These slightly different models 
suggest NUAK kinases might collaborate or have redundant functions at the actin stress fibers. In both 
scenarios, the presence of NUAKs at the actin stress fibers increases turnover, cell detachment and cell 
motility by keeping phosphorylated the MLC (Figure 2). In the same line, another study has showed that 
overexpression of NUAK2 in a human cancer cell line causes acute cell-cell detachment when the cells 
are exposed to glucose-free medium (Suzuki et al. 2003).   
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Figure 2: Proposed model of NUAK kinases role in actin stress fibers formation. NUAK kinases 
increase assembly of actin stress fibers by inhibiting the MLC phosphatase complex comprised of MYPT1 and PP1 
subunits. NUAK2 has been shown to inhibit the phosphatase by direct phosphorylation of MYPT1 but also in a kinase 
independent manner, likely to be allosteric inhibition for MRIP binding (indicated by blunted arrow). In the other hand, 
NUAK1 has been shown to directly interact with PP1 subunit and phosphorylate MYPT1. Phosphorylation of MYPT1 
by NUAK kinases or by ROCK kinases recruits 14-3-3 proteins that keep the MLC phosphatase away from actin stress 
fibers, promoting stress fibers formation. Currently, MYPT1 and MRIP are the only two known protein-protein interactions 
with NUAK2. Actin filaments shown in orange and myosin heads in blue (MLC in cyan). Dashed arrows indicate 
phosphorylation event (Koga and Ikebe, 2008; Vallenius et al., 2011; Y. Wang et al., 2009; Yamamoto et al., 2008; 
Zagórska et al., 2010).     
1.3.3   Role of NUAK2 in apoptosis and cell survival  
In addition to its role in regulating exercise-stimulated glucose transport, NUAK2 has also been shown 
to play a role in maintaining skeletal muscle mass (Lessard et al., 2017). Adult mice and humans displayed 
increased expression of NUAK2 in skeletal muscle upon aging and also in response to metabolic stress. 
Interestingly, the loss of NUAK2 also increased sensitivity of myocyte cultures to induced-palmitate 
apoptosis (Lessard et al., 2017). Moreover, mice carrying a muscle-specific NUAK2 dominant negative 
mutant kinase (SDN) had severe atrophy of muscle fibers (Lessard et al., 2017). Mechanistically, Lessard 
et al. showed these mice have impaired Rho signalling as they had decreased phosphorylation of MYPT1 
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Rho kinase Thr696 phosphorylation site and decreased expression of downstream Rho signalling targets, 
suggesting that defective Rho signalling may be involved in the apoptotic phenotypes upon NUAK2 loss.  
In vitro, primary myocytes cultures derived from SDN mice also showed the same pattern. When myocytes 
were exposed to palmitate, increased MYPT1 phosphorylation was observed and this effect was lost 
when NUAK2 was depleted from the cells (Lessard et al., 2017). It is well known that Rho/ROCK 
signalling is involved in apoptosis as it is required for formation of the apoptotic bodies and cell 
detachment (Street and Bryan, 2011). Constitutive ROCK activation is carried out by caspases that cut 
the regulatory domain at the C-terminus of the kinase. ROCK over-activation increases cell contraction 
and bud formation, characteristic of apoptotic cells, as well as cell detachment (Street and Bryan, 2011). 
ROCK inhibitors have been exploit as tumor therapy drugs because tumor cells use ROCK over-
activation to rearrange their cytoskeleton and acquire cell invasion and metastatic properties (Street and 
Bryan, 2011). Here, NUAK2 could be a linking protein between apoptosis cascade and actin stress fibers 
remodelling.  
The protective role of NUAK2 in cell survival has also been studied in tumour cells resistant to 
CD95 induced apoptosis (Legembre et al., 2004). Tumor cells resistant to CD95 apoptosis also show 
increased motility and invasiveness through activation of NFκB genes. NUAK2 was identified as one of 
the CD95 induced up-regulated genes. Overexpression of NUAK2 protected cells from CD95 induced 
apoptosis in a NFκB dependent manner, and tumor cells lacking NUAK2 were more susceptible to 
CD95 apoptosis. Moreover, this cells also showed a decreased motility and invasiveness capacity 
(Legembre et al., 2004).  In a similar line, the closely related NUAK1 has also been associated to apoptosis 
regulation as it is activated by PKB to promote cell survival in glucose starvation situations in vitro (Suzuki 
et al. 2003). 
1.4   Suggested functions of NUAK2 in tumorigenesis 
As mentioned, NUAK2 is activated by the tumor suppressor kinase LKB1 along with 11 other AMPK-
related kinases.  Inactivation mutations of LKB1 are frequently found in sporadic lung adenocarcinomas 
where inactivation increases tumor proliferation and metastases (Ji et al., 2007). Moreover, LKB1 
inactivation mutations underlie a hereditary condition, Peuth-Jeghers Syndrome (PJS), characterized by 
an increased predisposition to cancer and development of gastrointestinal polyposis (Giardiello et al., 
2000). Studies in the host lab have shown that depletion of LKB1 restricted only to stromal cells is 
sufficient to fully develop gastrointestinal polyposis in mice, resembling PJS polyposis (Katajisto et al., 
2008). Loss of LKB1 in mouse embryonic myofibroblasts causes contractility defects, shown by loss of 
actin stress fibers and aSMA (Vaahtomeri et al., 2008). However, the molecular mechanisms by which 
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LKB1 functions as a tumor suppressor remain unknown. Interestingly, NUAK2 along with NUAK1 are 
the LKB1 substrates involved in actin cytoskeleton dynamics, and depletion of NUAK2 also causes a 
reduction of actin stress fibers in MEFs (unpublished). Moreover, NUAK2 activity in vitro was 
dramatically reduced in absence of LKB1 and the NUAK2 derived T-loop peptide was a better substrate 
for LKB1 phosphorylation than AMPKα1 derived T-loop peptide (Lizcano et al., 2004). Together brings 
NUAK2 as one of the best candidates to mediate LKB1 function in stromal cells. In this line, a study 
using heterozygous NUAK2 mice revealed that these mice were more susceptible to azoymethane-
induced (AOM) colonic tumorigenesis (Tsuchihara et al., 2008).  
Contrarily to the putative tumor suppressor function of NUAK2 in gastrointestestinal tract, the 
literature of NUAK2 role in tumorigenesis is quite contradictory. Of the known biological functions of 
NUAK2, its involvement in cell survival and cell detachment as well as induction by metabolic stressors 
strongly suggests NUAK2 could play a prominent role as pro-tumorigenic kinase in tumor cells. Indeed, 
NUAK2 locus resides in chromosome 1q32, a region frequently amplified in human melanomas (Namiki, 
Coelho, et al., 2011). Accordingly, high levels of NUAK2 have an impact on survival rate of patients with 
acral melanomas and correlates with bad prognosis (Namiki, Coelho, et al., 2011). Moreover, using array-
CGH it has been identified that NUAK2 is amplified along with PTEN deficiency in a subset of 
melanomas and that this combination promotes melanoma cell proliferation through cyclin-dependent 
kinases (CDK) activation (Namiki et al., 2015). In addition, inhibition of NUAK2 in mice suppressed 
melanoma tumour growth (Namiki, Tanemura, et al., 2011). 
It is likely that NUAK2 dual role in tumorigenesis, as what happens with its regulation by cell 
stress, is highly cell context and cell type dependent, increasing the complexity of this kinase and putative 
future development of drug therapies.  
1.5   Proximity-dependent biotin labeling is a novel method to study protein-protein 
associations in vivo 
One of the challenges of this century is to characterize and map the whole network of intracellular 
protein-protein interactions, known as the cellular interactome. Knowing the structure and functional 
domains of a protein is often not enough to decipher its function inside the cell. To understand its 
biological relevance is more useful to identify its associations and partners and how they change over 
time. However, very often these interactions are weak, fast, transient, and highly cell context dependent 
making it challenging to successfully detect them. Proximity-dependent labelling by modifying enzymes 
is an approach that has been developed recently to screen and successfully identify these transient 
protein-protein interactions. Different modifying enzymes have been utilized, but all are based on the 
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same idea, to attach to a bait protein a small enzyme capable of tagging vicinity proteins by covalently 
modifying them (Rees et al., 2015). Afterwards the tag is used to isolate the covalently modified proteins 
by traditional affinity purification methods and further identify them by mass-spectrometry analysis. The 
BioID assay is one type of proximity-dependent labeling method based on biotin labeling, and it is the 
one I have used in this project to screen for new interactors with NUAK2.  
The BioID method was developed in 2012 by Roux et al. and it is based on a small modified 
bacterial biotin ligase, BirA*(R118G). This biotin ligase mediates the biotinylation process in a two-step 
reaction manner. During the first step, the biotin gets activated in the enzyme pocket site, by binding to 
ATP (biotinoyl-5’-AMP). In the second step, this unstable biotin reacts to a protein lysine residue creating 
an amide bond between the biotin and the lysine chain. The modified BirA*(R118G) has lower affinity to the 
reactive biotin and it releases the molecule from its catalytic pocket prematurely. The reactive biotinyol-
5’-AMP is unstable and rapidly interacts with any vicinity protein that has exposed a lysine residue. During 
the time the protein construct is expressed, the BirA keeps track of proteins that have passed nearby the 
protein of interest tagging them with biotin. Biotinylated proteins can easily be isolated by streptavidin 
affinity purification and identified by mass-spectrometry analysis (Figure 3) (Roux et al., 2012).  
One of the advantages of this method is that the protein of interest is expressed in the same 
organism so all the post-translational modifications can occur as long as the BirA does not interfere 
allosterically. Moreover, biotinylation is a very stable covalent modification and cells can be lysed with 
stringent methods, opening the possibility to study insoluble or inaccessible cellular structures like 
centromeres and nuclear lamina (Firat-Karalar et al., 2014; Fu et al., 2015). The method is not exempt 
from a few limitations. It is still an overexpression assay, and as often happens with overexpression 
analysis, the protein product might be toxic for the cells or aggregate in the wrong location. The fusion 
construct can also affect post-translation modifications and the size of BirA, taking as reference the 27 
kDa of GFP, is a bit bigger (35 kDa) so it can also affect folding and normal function of the protein. 
Recently, the same lab has released a smaller version of the biotin ligase to try to improve and reduce 
these limitations (Kim et al., 2016). All the potential problems mentioned need to be taken into account 
and functional validation of the fusion proteins by immunofluorescence and western blot is required 
prior to carrying out the whole BioID assay. Nonetheless, since the method was published in 2012, the 
BioID has extensively been used for a high variety of proteins and it has successfully served to study 
cellular structures that previously were quite troublesome, like centromeres, the nuclear complex pores 
or the nuclear lamina (Firat-Karalar et al. 2014; Kim et al. 2014; Fu et al. 2015).  
Background 
 
 10 
  
Figure 3: BioID assay. This proximity-dependent labeling method is based on the fusion of a promiscuous biotin ligase 
BirA*(R118G) to the protein of interest, represented here with NUAK2. This mutant BirA*(R118G) is able to biotinylate 
nonspecifically vicinity proteins overtime. The fusion protein construct is transfected in the cells and after 24 h incubation 
with media supplemented with biotin the cells are lysed and the biotinylated proteins can be isolated using streptavidin affinity 
purification methods. Finally, the biotinylated proteins can be identified by mass-spectrometry (Modified from Varnaitė and 
MacNeill, 2016). 
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2   Aims of the study 
 This Master’s thesis focuses on identification of novel protein-protein interactions of the NUAK2 
kinase with an aim to:  
I.   Provide insight on NUAK2 biological function through identification of proteins NUAK2 
interacts with in mammalian cells.  
II.   Provide insight on whether NUAK2 is involved in tumor suppression.  
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3   Material and methods 
3.1   Cell lines   
I used human embryonic kidney cells (HEK 293) for transient transfections and a Flp-In T-Rex 293 cell 
line for generation of stable cell lines expressing the different fusion proteins.  
The Flp-In T-Rex 293 cell line contains a single stably integrated FRT site in a transcriptomic 
active genomic locus and a randomly integrated tetracycline transactivation gene (tTA). The pcDNA5-
FRT/TO-FLAG-BirA*(R118G) expression vector used to generate the fusion proteins contains a 
hygromycin cassette that does not have starting codon and it is out of frame (Figure 4). After the FLP 
recombination event the opening reading frame (ORF) of the hygromycin cassette in the expression 
vector gets in frame with the promoter conferring hygromycin resistance to the cells. In addition to the 
hygromycin cassette, this expression vector contains a tetracycline-controlled promoter, commonly 
classified as Tet-Off system. The plasmid carries TetO operator sequences upstream the CMV promoter 
where the tTA can bind and repress vector expression (Figure 4). The vector expression is induced when 
tetracycline is supplemented to the media or when the plasmid is expressed in cells that lack tTA.  
The protein constructs generated with this plasmid, in addition to the BirA enzyme, they also 
contain a Flag tag at the N-terminus that can be utilized to visualize the protein construct by 
immunofluorescence and western blot (Figure 4). 
 
Figure 4 pcDNA5-FRT/TO-FLAG-BirA*(R118G) plasmid map. Diagram of the expression vector used in this 
project to create the protein constructs BirA-NUAK2, BirA-CCRK and BirA-GFP respectively. The promoter of the 
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vector is CMV with TetO operator sequences upstream where the tetracycline transactivator (tTA) can bind. The fusion 
protein contains a Flag tag in the N-terminus that can be utilized for functional validation. The vector also contains an 
ampicillin resistance cassette for bacterial selection and a hygromycin resistance cassette for generation of stable cell lines using 
Flp recombination.  
3.2   Plasmids 
Along with BirA-NUAK2 DNA construct, I also generated BirA-CCRK (as it was of interest for an 
independent project in the lab) and BirA-GFP to use as control for ubiquitous proteins.   
Plasmid Name Information Purpose 
pDEST27 - Hs - NUAK2 Mammalian expression vector.  It carries a human NUAK2 CDS.  
Template used to subclone 
NUAK2 CDS. 
pDEST27 - mm - CCRK Mammalian expression vector.  It carries a mouse CCRK CDS. 
Template used to subclone 
CCRK CDS. 
pcDNA6.2 - emGFP Mammalian expression vector.  It carries a GFP CDS. 
Template used to subclone GFP 
CDS.  
pcDNA5-FRT/TO-FLAG-
BirA*(R118G) 
Mammalian expression vector. 
Confers hygromycin resistance once 
the FRT site is recombined. CMV 
promoter, tetracycline inducible.   
Destination vector used to 
generate BirA fusion proteins.  
pOG44 Mammalian expression vector.  It carries the Flp recombinase CDS. Generation of stable cell lines. 
Table 1: Plasmids used in this project. CDS stands for coding DNA sequence. 
3.3   PCR primers  
ID Oligo Sequence (written from 5´to 3´ direction) 
NotI_Hs_NUAK2_F GAATTCGCGGCCGCGATGGAGTCGCTGGTTTTCG 
XhoI_Hs_NUAK2_R ACGGAGCTCGAGTCAGGTGAGCTTTGAGCA 
NotI_GFP_F ACGAATGCGGCCGCCATGGTGAGCAAGGGCGAGGA 
SalI_GFP_R ATTCGTGTCGACTTACGTTTCTCGTTCAGCTT 
NotI_Mm_CCRK_F ACGAATGCGGCCGCCATGGACCAGTATTGCATCCT 
SalI_Mm_CCRK_R ATTCGTGTCGACTCACCCCTCTGGGATGAAGGG 
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Table 2: Primers used in this project. First column indicates name of the primer with the restriction site sequence 
added and origin of the gene CDS; human (Hs) or mouse (Mm). All sequences are written in 5´to 3´direction. Restriction 
enzyme site highlighted in bold.    
3.4   Restriction enzymes 
Restriction enzyme name Sequence site Purpose 
HindIII A/AGCTT Restriction enzyme analysis 
NcoI C/CATGG Restriction enzyme analysis 
NotI GC/GGCCGC Cloning  
SalI G/TCGAC Cloning 
XhoI C/TCGAG Cloning 
Table 3: Restriction enzymes used in this project. All restriction enzymes are from New England Biolabs 
(NEB). 
3.5   Cell culture media  
If not mentioned otherwise, all mammalian cell lines used in this project were cultured in Dulbecco’s 
Modified Eagle Medium (DMEM) supplemented with 10% fetal bovine serum (FBS), 1% L-Glutamine 
and 1% penicillin/streptavidin mix (hereon called complete media). Cell cultures were incubated at 37°C 
5% CO2.  
3.6   Plasmid extraction 
Starter bacterial cultures (E.Coli DH5α) carrying the plasmids of interest (Table 1) were incubated 
overnight in lysogeny broth (LB) liquid medium supplemented with 100 µg/ml ampicillin using a shaker 
incubator (37°C 5% CO2). Bacterial cells were harvested by centrifugation (8000 rpm, 3 min, at room 
temperature (RT)). Cell lysis and plasmid extraction was done using a commercial spin column kit 
(QIAprep Spin Mniprep Kit #27104) following manufacturer’s instructions.  DNA was eluted in TE 
buffer (10mM Tris pH 8.0, 1mM EDTA) to a final volume of 50 µl and stored at 4°C. Sample quality 
and quantity was assessed using Nanodrop.  
3.7   PCR cloning 
Primer3 software (Untergasser et al., 2012) was used to design forward and reverse primers to amplify and 
obtain the coding DNA sequences (CDS) of NUAK2, CCRK and GFP, from expression plasmids 
provided by the lab (Table 1). A restriction enzyme site for NotI and XhoI at the 5’ and 3’ ends of the 
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forward and reverse primer was added respectively. Due to an inner XhoI site in the CDS of CCRK and 
GFP a compatible enzyme, SalI was used instead. SalI recognizes a slightly different DNA sequence 
(Table 3) but after cutting the DNA, it creates the same sticky ends than XhoI, therefore it can be used 
along with XhoI digested DNA products. PCR reactions were done in a final volume of 50 µl using the 
DNA polymerase Phusion (2mM NTPs, 10uM forward and reverse primers, 1X Phusion HF Buffer, 1.0 
units of Phusion enzyme NEB #M0530 and 200-250 ng of template), a termoresistant enzyme with 
proofreading capacity, to reduce probability of adding mistakes in the sequence that could affect 
downstream restriction enzyme reactions and subsequent cloning. The thermocycler programs used for 
each PCR reaction can be found in Appendix A.  The PCR products were purified from PCR incomplete 
products by running the samples in 1% agarose gels. The right PCR product band was cut from the gel 
and purified using the commercial QIAquick Gel extraction kit. Sample quality and concentration was 
measured using Nanodrop.  
3.8   Enzyme digestion and ligation 
1 µg of the destination vector, pcDNA5-FRT/TO-FLAG-BirA*(R118G), was digested in a sequential 
manner due to close proximity of NotI and XhoI restriction enzyme sites (10 base pairs). The vector was 
incubated 1 h at 37°C with NotI in a total reaction of 30 µl (1X NEB buffer 3.1, 1.0 unit NotI NEB 
#R0189) followed by 1 h at 37°C with XhoI in a total volume of 50 µl (1X NEB buffer 3.1, 1.0 units 
XhoI NEB #R0146). Salts were adjusted to the second reaction volume respectively. After digestion, the 
vector was dephosphorylated to reduce the amount of false positive clones due to re-ligation events using 
shrimp alkaline phosphatase (SAP).  
PCR products were double digested, 1 h at 37°C with NotI and XhoI added simultaneously in a 
50 µl reaction. All enzymes were heat inactivated at the end by incubating the reactions 20 min at 65°C.  
Ligation reactions were done using the T4 DNA ligase (NEB #M0202) in 10 µl reactions with a 
molar ratio of 1:3 vector to insert, and set overnight at 16°C in a thermocycler.  
3.9   Transformation  
E.Coli DH5a competent cells were transformed with the different ligation products by heat-shock 
inactivation procedure. In brief, competent cells were thawed on ice for 10 min and 2 µl of ligation 
product (~100 ng) was added to the cells mixing without vortexing nor pipetting the cells, only by swirling 
the tip of the pipette. Cells were left standing on ice for 30 min and then heat shocked at 42°C for 45 
seconds using a heat block and placed back on ice for 5 min. 250 µl of Super Optimal Broth medium 
(SOC) was added to cells and cultures were incubated for 1 h in a shaker (250 rpm, 37°C). Finally, 100µl 
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of cell mixture was plated on LB agar plates supplemented with 100 µg/ml ampicillin and left overnight 
in an incubator at 37°C. Screening for positive colonies carrying the plasmid of interest was assessed by 
restriction enzyme analysis (Table 3).   
3.10   Transient transfections 
20000 HEK293 cells were plated in 6 cm2 well plates in complete media without antibiotics and 
transfected the next morning with the pcDNA5-FRT/TO-FLAG-BirA*(R118G) – NUAK2/CCRK/GFP 
vector respectively using Lipofectamine2000 following manufacturer’s instructions (ThermoFisher). 
Media was changed to complete media 4 h after transfection. Next day, cells were supplemented with 50 
µM biotin and incubated 24 h before protein extraction.  
3.11   Immunofluorescence staining 
For immunofluorescence staining, 200000 HEK293 cells were plated on collagen coated coverslips 
overnight and transient transfected with the plasmids of interest next day. 4 h after transfection, media 
was complemented with 50 µM biotin and kept 24 h. Cells on coverslips were washed twice with PBS to 
remove free biotin and fixed by incubating 10 min with 4% PFA. To make cell membranes permeable to 
antibodies, the samples were treated with 0.1 % triton (diluted in PBS) for 10 min and to reduce 
background signal, samples were blocked 1 h at RT with 5% goat serum (diluted in PBS). Afterwards, 
samples were incubated 1 h at RT with anti-Flag (1:500 Sigma #F9291) followed by three PBS washes 
of 5 min each, and 1 h incubation at RT with the secondary antibody (1:400 Alexa fluor 594 anti-mouse). 
Samples were washed 5 min in PBS, stained 2 min with Hoechst (0.5 µg/ml) and washed again with PBS. 
Coverslips were mount with mowiol and stored at 4 ºC until imaged. Imaging was done using a Zeiss 
Axioplan 2 upright epifluorescence microscope. ImageJ was used to extract .tiff and merged color images 
from .zvi files.  
3.12   Protein extraction and immunoblotting 
HEK 293 cells were lysed using boiling SDS buffer (Tris 125mM pH 6.8, 2.5% SDS), kept at 90 ºC during 
10 min to denaturize all proteins and inactivate proteases and further homogenized by passing the 
samples through a 27 G needle 8 times. DS-assay was performed to assess protein sample concentrations 
prior immunoblotting following manufacturer’s instructions (BioRad). 20 mg of lysate was loaded in a 
10% SDS-PAGE gel, ran 2 h at 35 mA and transferred to a nitrocellulose membrane using wet blotting 
(1.5 h, 200 mA at 4 ºC). Membranes were blocked with 5% non-fat milk in TBST buffer (TBS, 0.1% 
tween 20) for 1 h at RT and left overnight incubating in a rotator with the primary antibody at 4°C 
(1:2000 anti-Flag M2 mouse, Sigma #F9291). Membranes were incubated with HRP-based secondary 
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antibodies 1 h at RT (HRP-anti-sreptavidin or HRP-anti-mouse accordingly at 1:5000 dilutions in 5% 
non-fat milk in TBST buffer). Triple TBST washes of 15 min were done between antibody incubations 
and prior film exposure. Supersignal femto chemiluminiscence reagents (ThermoFisher Scientific 
#34095) diluted 1 to 10 ml in TBS were used to expose membranes to films.  
3.13   Generation of stable cell lines 
Fuge6 transfection reagent (Promega #E2691) was used for double transfection of the Flp-In T-Rex 293 
cells with the pOG44 vector (vector carrying the Flipase recombinase) and the generated pcDNAFLAG-
BirA carrying the fusion constructs of interest, following manufacturer’s instructions. Hygromycing 
selection was started 3rd day after transfection. The cells were kept in selection media until the plates were 
confluent (~1 month) passaged twice and frozen in 90% FBS, 10% DMSO media. Criovials were stored 
at -135ºC.  
3.14   BioID assay 
Six confluent 15 cm2 dishes of FlpIn T-Rex 293 cells for each experimental condition were used as 
starting material for the BioID assay. When plates were 80% confluent, cells were incubated 24 h with 
50 µM biotin and 1µg/mL tetracycline in complete media to express the BirA-construct and induce BirA 
activity (as recommended by Roux et al. 2012). Cells were rinsed twice with PBS to remove free biotin 
from the medium before adding SDS cell lysis buffer (50 mM TrisCl pH 7.4, 500 mM NaCl, 0.2% SDS, 
1x protease inhibitor cocktail and 1mM DTT added just before use), scraped and harvested in eppendorf 
tubes, one for each condition (all carried on ice). The cell lysate was transferred to a 15 mL canonical 
tube and 240 µl of 20% Triton X-100 was added and mixed by trituration. Samples were sonicated (2 
sessions with 30 pulses) and afterwards 2 ml of prechilled 50 mM TrisCl pH 7.4 was added and mixed to 
increase favorable conditions for affinity capture. Sample was aliquoted evenly into 3 prechilled 2-ml 
tubes and spin down 10 min at 13000 rpm at 4°C. Meanwhile, 2-ml tubes were placed to a magnetic 
separation stand and filled with 0.75 ml of RT lysis buffer and 0.75 ml of RT 50mM TrisCl, pH 7.4. 
Streptavidin magnetic beads (Dynabeads MyOne Streptavidin C1, Invitrogen #65001 ) were resuspended 
by pipetting. 200 µl of streptavidin beads was added to each tube and let stand in the magnetic separation 
stand 3 min at RT. Once all the beads were accumulated on one side of the tube wall, the supernatant 
was removed by pipetting. After sample centrifugation, the supernatant was carefully transferred to the 
tubes on the magnetic stand, re-suspended along with the beads and let overnight incubating on a rotator 
at 4°C. Next day streptavidin beads were washed incubating the beads a total of 3 times, 8 min each, in 
a rotator with a serial of wash buffers, each one containing a smaller fraction of detergents to a final 1.5 
ml 50mM TrisCl, pH7.4 (first wash buffer contained 2% SDS. Second wash buffer had 0.1% deoxycholic 
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acid, 1% Triton X-100, 1mM EDTA, 500 mM NaCl, 50 mM HEPES, pH 7.5 and the final wash buffer 
had 0.5% deoxycholic acid, 0.5% NP-40, 1mM EDTA, 250mM LiCl and 10 mM TrisCl, pH 7.4). A 
magnetic stand was used between each wash to successfully remove the supernatant without losing the 
streptavidin beads.  
3.15   Data analysis 
Purified biotinylated proteins were sent to be analyzed by liquid-chromatography mass-spectrometry 
(LC-MS/MS) and protein identification at the Proteomics Unit of the University of Helsinki. The 
Proteomics Unit prepared the samples for mass-spectrometry, including separation from the streptavidin 
beads and trypsinization. SEQUEST search algorithm in Proteome Discoverer software (ThermoFisher 
Scientific) was used for peak extraction and MaxQuant software for protein identification (Cox and 
Mann, 2008).  
For this study, three other datasets created in the lab were also included as controls (Figure 7A) to 
subtract background proteins from NUAK2 dataset with the assumption that the proteins studied had 
independent function and localization with NUAK2. All the data processing was done uploading the 
excels provided by the Proteomics Unit to R/Bioconductor platform. A protein identified in NUAK2 
dataset was considered specific for NUAK2 if it was not found in any of the other datasets or if the ratio 
of spectral counts was 3 fold higher than in any other dataset (as suggested by Roux et al. 2012).  
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4   Results 
4.1   Functional validation of fusion constructs and stable cell lines generated.  
293 HEK cells were transiently transfected with vectors carrying the different DNA constructs generated 
(BirA-NUAK2, BirA-CCRK and BirA-GFP respectively) and containing a Flag tag at the N-terminus of 
the BirA part. Subsequent immunofluorescence staining with anti-Flag demonstrated cytoplasmic 
staining in a subset of the transiently transfected cells as expected. Based on the analysis the BirA-
NUAK2 plasmid showed lower transfection efficiency compared to the other constructs, which may be 
due to bigger size of the plasmid. As expected, the GFP signal in the BirA-GFP transfection overlapped 
with the anti-Flag signal (Figure 5).  
 
Figure 5: Immunofluoresence analysis of 293 HEK cells transiently transfected with the 
indicated BirA fusion constructs. Anti-Flag staining and overall images with nuclear staining (Hoechst) and GFP 
in case of the BirA-GFP fusion construct. 
Induction of the generated stable HEK293 lines expressing BirA-NUAK2 when supplemented 
with tetracycline was validated by western blot, using cell lysates of cells previously cultured 24 h with 
media supplemented with or without 50 µM biotin and 1 µg/ml tetracycline (Figure 6). As expected, 
BirA was only capable of biotinylating proteins when the media was supplemented with both, tetracycline 
and biotin (Figure 6). It should be noted that due to the fusion construct, the fusion protein itself gets 
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highly self-biotinylated and this can be already spotted in the streptavidin-HRP western blots (red arrows 
Figure 6). From the three stable cell lines generated, BirA-NUAK2 had the lowest overexpression 
compared to the other constructs (α-Flag Figure 6B), being BirA-GFP the highest expressed. In fact, 
BirA-GFP also showed some residual expression in conditions where the gene should not be expressed 
(green arrows Figure 6). This is likely due to differences in expression and binding of the tetracycline 
repressor as the repressor gene is randomly integrated in the genome of the Flp-In T-Rex 293 cells when 
these are generated, and they can be under different promoters. The bands observed in all the conditions 
where the plasmid is not expressed nor biotin is supplemented are endogenous biotinylated proteins. 
 
Figure 6: Immunobloting of the stable 293 FlpIn TRex cell lines generated. A, B. Streptavidin-HRP 
and anti-Flag blotting of protein cell lysates from BirA-NUAK2, BirA-CCRK and BirA-GFP 293 HEK FlpIn T-
Rex cell lines supplemented 24h with or without 50 µM biotin, 1µg/ml tetracycline. Red arrow indicates band likely to be 
the self-biotinylated construct (BirA-NUAK2 109kDa, BirA-CCRK 78 kDa, BirA-GFP 68 kDa respectively). Green 
arrows indicate BirA-GFP protein expression leakage.  
4.2   BioID assay with BirA-NUAK2 identified previously known protein-protein NUAK2 
interactions as well as potential new candidates.  
Biotinylated proteins from cells lysates were purified using streptavidin magnetic beads and mass-
spectrometry analysis was carried out in the Proteomics Unit from the University of Helsinki. The output 
was joined with other datasets produced independently in the lab (Figure 7A). Each dataset was used as 
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control of the other datasets to remove background proteins with the assumption that each protein has 
independent functions, and therefore they would not share any substrate.  Any shared protein identified 
between datasets was considered background, ubiquitous protein, unless one of the datasets had a 3 fold 
higher spectral count than the other, following original paper recommendations.(Roux et al., 2012). 
Taking BirA-NUAK2 dataset as reference, the different proteins identified after background removal 
were narrowed down from 694 to 108 (Figure 7B). 
 
Figure 7: BioID datasets used in this project. A. Number of different proteins identified in each BirA fusion 
construct dataset. Indicated in blue the datasets generated in this thesis. In pink, datasets included as controls but not 
generated in this study. B. Venn diagram with the overlaps between datasets (created with Jvenn web-tool, Bardou et al. 
2014). The diagram only shows the total shared overlap number and the result of subtracting all shared overlaps per each 
dataset.  
Ranking this list by abundance of unique peptide hits identified for each protein group it was 
promising to see in the top 3 of the list the two previously published interactions with NUAK2, MYPT1 
and MRIP, in first and second place respectively, followed by NUAK2 itself (Table 4) (Vallenius et al., 
2011; Yamamoto et al., 2008). Self-biotinylation events of the fusion construct were expected as it is the 
closest protein to BirA and in the western blots it was already visible (red arrows in Figure 6). In lower 
ranks but in high abundance 14-3-3 proteins and several phosphatase catalytic subunits from the MLC 
phosphatase complex were also detected. As already mentioned, recruitment of 14-3-3 by 
phosphorylation of MYPT1 is one of the mechanisms to inhibit the phosphatase’s recruitment to actin 
stress fibers and subsequent dephosphorylation of MLC (Koga and Ikebe, 2008).  
Importantly for the aim to identify new interactors the screen identified 108 new potential 
interactors. Interestingly, these include highly ranked proteins previously linked with functions of interest 
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regarding NUAK2 such as Cytospin-A, Serpin B4 and Serpin B3 (Table 4), ranking higher than 14-3-3 
and PP1 regulatory subunits. Cytospin-A is a crosslinking protein between actin stress fibers and 
microtubules.    
Rank Accession Protein name Description 
1 O14974 MYPT1 Protein phosphatase 1 regulatory subunit 12A  
2 Q6WCQ1  MRIP Myosin phosphatase Rho-interacting protein  
3 Q9H093 NUAK2 NUAK family, SNF1-like kinase 2  
4 Q69YQ0 CYTSA Cytospin-A  
5 P62140 PP1B Serine/threonine-protein phosphatase PP1-beta catalytic subunit  
6 P48594 SPB4 Serpin B4  
7 P29508 SPB3 Serpin B3  
8 P31947 1433S 14-3-3 protein sigma  
9 Q9BZL4 PP12C Protein phosphatase 1 regulatory subunit 12C  
10 Q8IXQ4 GPAM1 GPALPP motifs-containing protein 1  
11 P20671 H2A1D Histone H2A type 1-D  
12 Q96HR8 NAF1 H/ACA ribonucleoprotein complex non-core subunit NAF1  
13 O60237 MYPT2 Protein phosphatase 1 regulatory subunit 12B  
14 P01857 IGHG1 Ig gamma-1 chain C region  
15 O15446 RPA34 DNA-directed RNA polymerase I subunit RPA34  
Table 4: Top 15 proteins identified by BioID of BirA-NUAK2 fusion construct. Ranked by number 
of unique peptides identified for each protein group. Shaded in blue, proteins of the MLC phosphatase complex and associated 
proteins. In bold previously known partners of NUAK2. Shaded in yellow, potential new interactors of NUAK2.  
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5   Discussion and conclusions 
Little is known about the biological relevance of the NUAK2 kinase and its involvement in LKB1 
tumorigenesis, in part due to limited knowledge of its protein-protein interactions. In this project, I 
generated a stable cell line expressing an inducible vector carrying a BirA-NUAK2 fusion protein and 
utilized the BioID method to successfully identify new protein-protein associations as well as previously 
known interactions.   
All the subunits of the MLC phosphatase and classic associated proteins like 14-3-3 were found 
in the top 15 of the ranked proteins identified with the BioID method (Table 4). This clearly indicated 
NUAK2 is localized around the MLC phosphatase complex. It should be mentioned that the results were 
from a single experiment, without replicates, and this could increase false positives. However, the fact 
that previously known interactions, MYPT1 and MRIP, were the two most biotinylated proteins by BirA-
NUAK2, ranking higher than self-biotinylation events, gives us confidence to trust the results. The 
screening also identified three new potential protein-protein associations discussed more in detail below 
(Table 4). A technical comment, BirA-GFP and BirA alone constructs were used to try to identify 
ubiquitous proteins. However, both of these constructs had very high levels of overexpression. BirA-
GFP was detected in conditions where the gene expression or BirA activity was not induced (as marked 
with green arrows in Figure 6). Moreover, likely due to small size and to the fact that these constructs 
do not localize to any particular location inside the cell, a big fraction of proteins identified by  the BioID 
were not shared with the other BirA protein constructs (Figure 7B). Interestingly, background removal 
of ubiquitous proteins using as control independent kinases (like BirA-CCRK and BirA-ICK) proved to 
be very successful as it detected the same fraction of ubiquitous proteins than BirA-GFP or BirA alone 
(~100) with the additional advantage of revealing biological information regarding their own protein-
protein associations. With these results, I would recommend to use independent proteins as internal 
controls for each other, rather than a ubiquitous construct like BirA-GFP, for further studies.  
 The most promising candidate, ranked in 4th position, was Cytospin-A (Table 4). Cytospin-A is 
a crosslinking protein that has not been extensively studied. Cytospin-A was one of the genes identified 
mutated in oblique facial clefts (Saadi et al., 2011). This congenital facial malformation is caused partly 
due to failure in epithelial-mesenchymal transdifferentiation, and therefore abnormal cell-cell detachment 
during delamination of the cranial neural crest cells (Saadi et al., 2011; Wilson et al., 2016). Cells lacking 
Cytospin-A had increased adherent junctions stability indicated by increased E-cadherin and β-catenin at 
the junctions (Wilson et al., 2016). These cells also showed increased actin stress fibers but they were 
randomly organized and more prominent in the middle of the cell. Cytospin-A was characterized as a 
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crosslink associated protein between microtubules and actin cytoskeleton because overexpression in cells 
co-localized with both, tubulin and actin, stabilizing microtubules (Saadi et al., 2011). It is suggested that 
Cytospin-A may mediate transduction of signals required to reorganize actin stress fibers during cell 
adhesion (Saadi et al., 2011). It is too early to speculate the role of this protein in NUAK2-dependent 
actin stress fibers reorganization but it could be assessed using the NUAK2 actin stress remodeling 
phenotype as a functional assay. The CDS of Cytospin-A is commercially available and it could be 
subcloned and used in overexpression assays and also co-immunoprecipitation to validate the interaction 
with NUAK2.  
 Other promising candidates include proteases inhibitors, SERPINB3 and SERPINB4 
respectively. They both have been found overexpressed in many advanced carcinomas and idiopathic  
pulmonary fibrosis (Calabrese et al., 2012; Turato et al., 2014). In particular, SERPINB3 has been shown 
to protect tumor cells from apoptosis by inhibiting release of cytochrome c from the mitochondria 
(Vidalino et al., 2009). It is not evident in this case how to investigate its putative association with NUAK2 
as currently there is no functional assay to work on. The CDS of these protease inhibitors are also 
available so validation of the physical interaction could be approached by co-immunoprecipitation or 
cross-linking protein interaction assays. Optimization of these methods is usually demanding but the 
approach would validate the interaction with NUAK2.  
Interestingly, NUAK1 was not found in the whole dataset. It has been shown to be associated to 
MLC phosphatase and inactivate the MYPT1 by phosphorylation (Zagórska et al., 2010) and therefore, 
should localize quite close to NUAK2. However, it was not detected in the whole screen (nor before 
subtracting background proteins). This negative result could be due to low protein levels of endogenous 
NUAK1 or allosteric interactions that could have kept NUAK1 out of reach from BirA biotinylation. 
There is no evidence that NUAKs associate in a complex to perform their functions and this negative 
result would not point to that direction. In any case, further validation of the protein interactions with 
NUAK2 should also include NUAK1 as these two kinases are closely related and they could still share 
many of their biological functions and protein partners.  
As far as the protein-protein associations discussed the dataset is quite narrow and the spectral 
counts and coverage of the proteins identified drops quickly below the top 15. Since previous literature 
shows NUAK2 regulation and functions appear to be cell type and context dependent, it could reveal 
more information to use the BioID method with cells under different cellular stress conditions as well as 
in different cell types. This could reveal if NUAK2 versatility is due to different protein-protein 
associations or if the different functions described for NUAK2 are linked at a molecular level. 
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In conclusion, in this project I created a BirA-NUAK2 protein construct and generated an 
inducible 293 cell line that expressed the fusion protein after media supplementation with tetracycline. I 
tested by immunoblotting and immunofluorescence that the BirA-NUAK2 was functional and that BirA 
was able to biotinylate vicinity proteins after addition of biotin to the media. Finally, I utilized a proximity- 
dependent biotin labeling method, the BioID, to identify novel protein-protein associations. The 
screening identified previously known protein interactions, MYPT1 and MRIP, and also 108 new 
candidates, including Cytospin-A interesting due to its association and effect on actin stress fibers. The 
results thus provide potential new information on NUAK2 biology and may provide tools to study its 
role in tumorigenesis. Validation of the protein-protein interactions and their potential role in NUAK2 
functions should be addressed in the future e.g. by using NUAK2-dependent actin stress fibers 
remodeling phenotype as a functional assay and by co-immunoprecipitation methods.  
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Appendix A.   Thermocycler programs  
 
Thermocycler program for NUAK2 CDS 
 
 
Thermocycler program of CCRK and GFP CDS 
 
